Syneos Health Schedules Third Quarter 2021 Earnings Call for Wednesday, November 3rd, 2021
October 19, 2021 09:32 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2021 financial...
Syneos Health Acquires RxDataScience
October 06, 2021 08:16 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of...
Syneos Health Acquires StudyKIK
September 14, 2021 17:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a...
Syneos Health and Ride Health Partner to Improve Clinical Trial Recruitment and Retention
September 09, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic...
Syneos Health to Present at the 2021 Baird Global Healthcare Conference
August 30, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Reports Second Quarter 2021 Results
August 09, 2021 06:12 ET
|
Syneos Health, Inc.
Highlights Second quarter revenue of $1,282.6 million, increased 6.1% sequentially and 26.6% year-over-year.Clinical Solutions net new business awards of $1,436.2 million for the second quarter,...
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
August 02, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH) and Aetion® announced a partnership to provide regulatory-grade data and analytics-driven solutions to...
Syneos Health Names Michael Brooks Chief Development Officer
July 14, 2021 08:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., July 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael...
Syneos Health Schedules Second Quarter 2021 Earnings Call for Monday, August 9, 2021
July 12, 2021 16:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., July 12, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial...
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors
June 21, 2021 08:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today expanded its Decentralized Clinical Trial...